Passer au contenu Aller au pied de page
Adalimumab-Bwwd: Benefits, Reviews, Info, Side Effects!
Détails de la prescription
Adalimumab-Bwwd
Adalimumab, Humira
Adalimumab
Biologic
Médicaments
Sur ordonnance uniquement
Adalimumab-Bwwd is a biosimilar to the reference product Humira (adalimumab). It is used to treat various inflammatory conditions. Here are the benefits in a comma-separated list: reduces inflammation, alleviates symptoms of rheumatoid arthritis, treats psoriatic arthritis, manages ankylosing spondylitis, helps with Crohn’s disease, treats ulcerative colitis, improves symptoms of plaque psoriasis, manages hidradenitis suppurativa, treats uveitis.
Abdominal Pain, Back Pain, Dizziness, Fatigue, Headache, Hypertension, Increased Liver Enzymes, Injection Site Reactions, Nausea, Rash, Sinusitis, Upper Respiratory Tract Infections, Urinary Tract Infections
Adalimumab-bwwd is a biosimilar to the original biologic drug adalimumab, which is commonly used to treat various inflammatory conditions such as rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn’s disease, ulcerative colitis, and plaque psoriasis. The average dosage of adalimumab (and its biosimilars like adalimumab-bwwd) can vary depending on the specific condition being treated. However, a common dosing regimen for adults with rheumatoid arthritis, for example, is: – An initial dose of 160 mg, followed by 80 mg two weeks later, and then 40 mg every other week. It’s important to note that the exact dosage and frequency can vary based on the specific condition, patient response, and other individual factors. Therefore, it’s crucial for patients to follow the dosing instructions provided by their healthcare provider.
Rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, crohn’s disease, ulcerative colitis, plaque psoriasis, hidradenitis suppurativa, uveitis
Adalimumab-Bwwd has a favorable safety profile.
Aucune interaction signalée
$1,000 – $2,000
$5,306.99

Un résumé de

Adalimumab-Bwwd

Adalimumab-Bwwd is a medication that falls under the category of biologic drugs, specifically a tumor necrosis factor (TNF) inhibitor. It is commonly used to treat a variety of inflammatory conditions such as rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn’s disease, and ulcerative colitis.

This medication works by targeting and blocking TNF, a protein in the body that plays a key role in the inflammatory response. By inhibiting TNF, Adalimumab-Bwwd helps to reduce inflammation and alleviate symptoms associated with these conditions.

It is typically administered via subcutaneous injection and the frequency of dosing can vary depending on the condition being treated. Adalimumab-Bwwd has been shown to be effective in managing symptoms and improving quality of life for many patients.

As with any medication, there are potential side effects to be aware of. Common side effects of Adalimumab-Bwwd may include injection site reactions, headaches, and upper respiratory infections. More serious side effects such as infections and allergic reactions are possible but rare.

It is important to discuss with your healthcare provider if Adalimumab-Bwwd is the right treatment option for you. They can provide guidance on dosing, monitoring for side effects, and any potential drug interactions.

Overall, Adalimumab-Bwwd is a valuable medication in the treatment of inflammatory conditions and has helped many patients find relief from their symptoms. If you have any questions or concerns about this medication, do not hesitate to reach out to your healthcare provider for more information.

Avis de non-responsabilité juridique de RxDb

Les informations fournies sur RxDB.net sont fournies à titre informatif uniquement et ne sont pas destinées à remplacer un avis médical professionnel, un diagnostic ou un traitement. Consultez toujours un professionnel de la santé qualifié, tel qu'un médecin ou un pharmacien, pour toute question ou préoccupation concernant votre santé, vos médicaments ou votre état de santé. Vous vous fiez entièrement aux informations fournies sur ce site Web à vos propres risques. RxDB.net ne fournit pas de services médicaux ou pharmaceutiques et n'est pas responsable des décisions prises sur la base des informations contenues dans le présent document.

DERNIÈRE MISE À JOUR DE LA PAGE

0
J'aimerais connaître votre avis, n'hésitez pas à commenter.x
fr_CAFR